Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer

New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loanCHASKA, Minn., May 22, 2023 -- Lifecore Biomedical, Inc. , a... | May 22, 2023

Related Keywords

Jamesg Hall , ,Exchange Commission ,Lifecore Biomedical Inc ,Company Nasdaq ,Company Current Report On Form ,Securities Exchange ,Chief Executive Officer ,Restated Supply ,Restated Supply Agreement ,Current Report ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Quarterly Reports ,Annual Report ,Lifecore Biomedical ,Nc Stock Exchange ,News ,Information ,Press Release ,Few ,Billion ,Credit ,Arrangements ,Nclude ,Agreement ,End ,Equipment ,Sale ,Leaseback ,O ,Eplace ,Xisting ,Term ,Bay ,023 ,Ifecore Lfcr Us5147661046 ,